CellaVision supports Medical Technology education across the U.S. and Canada

Accurately assessing the morphology of blood cells is one of the most difficult procedures performed in the clinical laboratory. It is a skill that requires both effective training as a student, and significant experience on-the-job.

 

"Once we discovered that the majority of the over 300 MT and MLT programs in North America have very limited budgets, we accepted the challenge to allow free and easy access to our software to all programs out there, said Ron Hagner, CellaVision's Group Vice President, North America. "We are donating up to $3,000,000 in software to the institutions which join the initiative."

 

Kathleen Finnegan, MS MT(ASCP)SH, Clinical Associate Professor and Chair of the Clinical Laboratory Sciences Program at the State University of New York at Stony Brook, is very appreciative that CellaVision has taken this step: "CellaVision's initiative will be very well received by the educators of Clinical Laboratory Sciences /Medical Technology Programs. Having this educational tool is an asset for teaching cell morphology. It gives students an incredible visual of all the characteristics of blood cells. This teaching software will ensure that our graduates are ready for the increasing use of digital imaging and the work force. Thank you CellaVision for helping educators train better technologists and for helping students become proficient in cell identification".

 

Beginning immediately, all University and College Medical Technology and Clinical Laboratory Science Programs in North America can join the initiative just by contacting na.info@cellavision.com.

 

The CellaVision® Competency Software is a program for education and competency testing of manual blood cell differentials in laboratories. It was originally developed for the CellaVision® DM96 digital cell morphology system currently being used in over 150 labs in North America alone. The two products together improve the efficiency, consistency and connectivity of the manual differentials being performed on peripheral blood and body fluids.

 

 

Ron Hagner, Group Vice President, North America

Phone: 919-619-3909. E-mail: ron.hagner@cellavision.com

 

 

CellaVision AB develops, markets, and sells market leading image analysis based systems for routine analysis of blood and other body fluids. The company has a core competence in development of software and hardware for automatic image analysis of cells and cell changes for applications in health and medical care. The company develops and markets systems for automatic differentials of white blood cells and red morphology, and software for education and quality assurance of differentials. The company's associates have expertise in advanced imaging analysis, artificial intelligence, and automated microscopy.

 

The company headquarters are in Lund, Sweden. The company also has subsidiaries in Jupiter, Florida, Toronto, Canada and Yokohama, Japan. For more information, visit www.cellavision.com.

 

CellaVision is listed on First North at the OMX Stockholm Stock Exchange. The company's Certified Advisor is Remium AB.